logo
 
The scientist, Arun K Shanker of Hyderabad-based Central Research Institute for Dryland Agriculture (CRIDA), who works on computational genome analysis and in vivo validation of genes, told The New Indian Express that he started off his research by studying genome sequence of the COVID-19 virus available at the NCBI repository and conducted a whole genome analysis to see if there were matches with any other known genomic sequence.

They observed that two particular non-structured proteins of COVID-19 virus matched with non-structured proteins from the earlier version of Coronavirus that had affected



humans — Severe Acute Respiratory Syndrome Coronavirus also known as SARS CoV.

The scientist, along with his team of two other scientists searched these proteins were found to bind with two separate compounds, Aza-Peptide Epoxide (APE) and GRL0617, that inhibited the ability of the virus to replicate, impairing the virus completely.

Moreover, it was also found that the site where the two compounds APE and GRL0617 bound to the SARS CoV virus, was the same as that in the COVID-19 virus. This, Dr Shanker said, shows that the two compounds can be used as anti-virals against the COVID-19.
No Comments For This Post, Be first to write a Comment.
Leave a Comment
Name:
Email:
Comment:
Enter the code shown:


Can't read the image? click here to refresh
etemaad live tv watch now

Todays Epaper

English Weekly

neerus indian ethnic wear
Latest Urdu News

Do you think AAP will perform better in Delhi polls without alliance?

Yes
No
Can't Say